4.4 Article

Reproducibility of semi-automatic coronary plaque quantification in coronary CT angiography with sub-mSv radiation dose

Journal

JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY
Volume 10, Issue 2, Pages 114-120

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcct.2015.11.003

Keywords

Coronary CT angiography; Coronary artery disease; Coronary plaque imaging

Ask authors/readers for more resources

Introduction: Coronary computed tomographic angiography (CTA) can characterize coronary atherosclerotic plaque components as calcified and non-calcified. Quantitative measurements of coronary plaque burden by coronary CTA may play a role in serial studies to determine disease progression or response to medical therapies. The reproducibility from repeated assessment of such quantitative measurements from low-radiation dose coronary CTA has not been previously assessed. Purpose: To evaluate the interscan, interobserver and intraobserver reproducibility for coronary plaque volume assessment using semi-automatic plaque analyses algorithm in low radiation dose coronary CTA. Methods: In 50 consecutive patients undergoing two 128-slice dual source CT scans within 12 days with a mean radiation dose of 0.7 mSv per coronary CTA, the interscan, interobserver and intraobserver reproducibility of coronary plaque assessment using validated software (AutoPlaq) were evaluated. Results: Interscan, interobserver and intraobserver agreement for non-calcified and calcified plaque volumes were excellent (Spearman rho 0.87-0.99). Interscan mean percentage difference in non-calcified and calcified plaque volumes were 0.1% (p = 0.8) and 1.9% (p = 0.19) with limits of agreement of +/- 11% and +/- 48.5%; per inter-and intraobserver mean percentage differences were 0.1% (p = 0.25) and 0.3% (p = 0.001), and 0.3% (p = 0.33) and 0.4% (p = 0.59) with limits of agreement of +/- 7% and +/- 32.9%, and +/- 6.6% and +/- 32.1%, respectively. Conclusion: A semi-automatic plaque assessment algorithm in repeated low radiation dose coronary CTA allows for high reproducibility of coronary plaque characterization and quantification measures. (C) 2016 Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation

Thomas Jensen, Pernille G. Thrane, Kevin K. W. Olesen, Morten Wurtz, Martin Bodtker Mortensen, Christine Gyldenkerne, Troels Thim, Bjarne Linde Norgaard, Jesper Moller Jensen, Steen Dalby Kristensen, Jens C. Nielsen, John W. Eikelboom, Michael Maeng

Summary: The study compared the risks of bleeding and ischemic events in patients with atrial fibrillation (AF) treated with anticoagulant monotherapy or dual therapy after 1 year of percutaneous coronary intervention (PCI). The results showed that the risks were similar between monotherapy and dual therapy, as well as between DOAC and VKA monotherapy.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2023)

Article Cardiac & Cardiovascular Systems

Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II

Christine Gyldenkerne, Michael Maeng, Lars Kjoller-Hansen, Akiko Maehara, Zhipeng Zhou, Ori Ben-Yehuda, Hans Erik Botker, Thomas Engstrom, Mitsuaki Matsumura, Gary S. Mintz, Ole Froebert, Jonas Persson, Rune Wiseth, Alf I. Larsen, Lisette O. Jensen, Jan E. Nordrehaug, Oyvind Bleie, Elmir Omerovic, Claes Held, Stefan K. James, Ziad A. Ali, Hans C. Rosen, Gregg W. Stone, David Erlinge

Summary: Patients with diabetes have a higher risk of major adverse cardiac events due to both treated culprit lesions and untreated nonculprit lesions. However, this study did not identify diabetes-related high-risk plaque characteristics using multimodality imaging.

CIRCULATION (2023)

Article Cardiac & Cardiovascular Systems

Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry

Martin Bodtker Mortensen, Omar Dzaye, Hans Erik Botker, Jesper Moller Jensen, Michael Maeng, Jacob Fog Bentzon, Helle Kanstrup, Henrik Toft Sorensen, Jonathon Leipsic, Ron Blankstein, Khurram Nasir, Michael J. Blaha, Bjarne Linde Norgaard

Summary: Low-density lipoprotein cholesterol (LDL-C) is associated with atherosclerotic cardiovascular disease (ASCVD), but its association with ASCVD risk is modified by the presence of coronary artery calcification (CAC). This study found that LDL-C is only associated with ASCVD events in patients with CAC, and not in those without CAC. This information is valuable for individualized risk assessment among middle-aged people with or without coronary atherosclerosis.

CIRCULATION (2023)

Article Clinical Neurology

Myopathy as a cause of Long COVID fatigue: Evidence from quantitative and single fiber EMG and muscle histopathology

Jane Agergaard, Benjamin Yamin Ali Khan, Thomas Engell-Sorensen, Berit Schiottz-Christensen, Lars ostergaard, Eva K. Hejbol, Henrik D. Schroder, Henning Andersen, Jakob Udby Blicher, Thomas Holm Pedersen, Thomas Harbo, Hatice Tankisi, M. U. L. T. I. C. O. V. Consortium MULTICOV Consortium

Summary: This study examined 84 patients with long COVID using qEMG and sfEMG, and performed muscle biopsies in a subset of patients. The results showed that the mean MUP duration was decreased in >= 1 muscles in 52% of the patients, and the mean jitter was increased in 17% of the patients in the tibialis anterior and 25% in the extensor digitorum communis. Muscle biopsies revealed damage of terminal nerves and motor endplate with abundant basal lamina material. These findings suggest a muscle pathophysiology behind fatigue in long COVID.

CLINICAL NEUROPHYSIOLOGY (2023)

Review Pharmacology & Pharmacy

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning

Peter Ferdinandy, Ioanna Andreadou, Gary F. Baxter, Hans Erik Botker, Sean M. Davidson, Dobromir Dobrev, Bernard J. Gersh, Gerd Heusch, Sandrine Lecour, Marisol Ruiz-Meana, Coert J. Zuurbier, Derek J. Hausenloy, Rainer Schulz

Summary: Preconditioning, postconditioning, and remote conditioning of the myocardium have the potential to provide novel therapeutic paradigms for cardioprotection. However, the lack of rigorous preclinical evaluation and consideration of cardiovascular risk factors and comorbidities may be a major reason for the failure to develop cardioprotective drugs.

PHARMACOLOGICAL REVIEWS (2023)

Article Cardiac & Cardiovascular Systems

Cardiac computed tomography following Watchman FLX implantation: device-related thrombus or device healing?

Anders Dahl Kramer, Kasper Korsholm, Jesper Moller Jensen, Bjarne Linde Norgaard, Srikara Peelukhana, Thomas Herbst, Rodney Horton, Saibal Kar, Jacqueline Saw, Mohamad Alkhouli, Jens Erik Nielsen-Kudsk

Summary: This retrospective observational study investigated the cardiac CT findings during follow-up after Watchman FLX implantation, focusing on hypoattenuated thickening (HAT) and device-related thrombosis (DRT). The study found that subfabric hypoattenuation and flat sessile HAT were frequent CT findings, likely representing benign device healing and endothelialization, while pedunculated HAT and protruding HAT were infrequent findings that might represent DRT.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2023)

Article Medicine, General & Internal

Long-Term Follow-Up After Acute Myocardial Infarction According to Beta-Blocker Dose

Susanne Bendesgaard Pedersen, Jens Cosedis Nielsen, Hans Erik Botker, Aparna Udupi, Jeffrey J. Goldberger

Summary: This study aimed to investigate the association between beta-blocker dose and mortality following acute myocardial infarction. A nationwide cohort study in Denmark was conducted, and the results showed that any dose of beta-blocker was associated with a significant reduction in mortality compared to no treatment. The largest reduction in mortality was observed within the first year after acute myocardial infarction for doses >25%-50% of the recommended target dose, suggesting that higher doses are unnecessary.

AMERICAN JOURNAL OF MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Coronary Inflammation and Plaque Vulnerability: A Coronary Computed Tomography and Optical Coherence Tomography Study

Haruhito Yuki, Tomoyo Sugiyama, Keishi Suzuki, Daisuke Kinoshita, Takayuki Niida, Akihiro Nakajima, Makoto Araki, Damini Dey, Hang Lee, Iris McNulty, Sunao Nakamura, Tsunekazu Kakuta, Ik-Kyung Jang

Summary: This study examined the relationship between the level of coronary artery inflammation and plaque characteristics in patients with coronary artery disease using computed tomography angiography and optical coherence tomography. The results showed that patients with high levels of coronary artery inflammation were more likely to have plaque vulnerability features such as lipid-rich plaque, macrophage, microchannels, plaque rupture, and layered plaque. This suggests that vascular inflammation and plaque vulnerability are intimately related.

CIRCULATION-CARDIOVASCULAR IMAGING (2023)

Editorial Material Cardiac & Cardiovascular Systems

Primordial non-responsiveness: a neglected obstacle to cardioprotection

Gerd Heusch, Hans Erik Botker, Peter Ferdinandy, Rainer Schulz

EUROPEAN HEART JOURNAL (2023)

Article Physiology

Low-load blood flow-restricted resistance exercise produces fiber type-independent hypertrophy and improves muscle functional capacity in older individuals

Jakob Wang, Anna-Maria Godsk Mogensen, Frederik Thybo, Magnus Brandbyge, Jonas Brorson, Gerrit van Hall, Jakob Agergaard, Frank Vincenzo de Paoli, Benjamin F. Miller, Hans Erik Botker, Jean Farup, Kristian Vissing

Summary: This study found that low-load blood flow-restricted resistance exercise (BFRRE) is effective in promoting muscle hypertrophy and improving muscle function in older individuals. However, its impact on age-related skeletal muscle decay at a cellular level is still unclear. BFRRE resulted in significant increases in muscle fiber morphology, integrated muscle protein synthesis, and muscle functional capacity without changes in muscle stem cells (MuSCs) and myonuclear content.

JOURNAL OF APPLIED PHYSIOLOGY (2023)

Article Medicine, General & Internal

Migraine and risk of premature myocardial infarction and stroke among men and women: A Danish population-based cohort study

Cecilia Hvitfeldt Fuglsang, Lars Pedersen, Morten Schmidt, Jan Vandenbroucke, Hans Erik Botker, Henrik Toft Sorensen

Summary: This study used Danish national registries to examine the impact of migraine on the risk of premature myocardial infarction (MI) and ischemic/hemorrhagic stroke among men and women. They found that migraine was associated with similarly increased risk of premature ischemic stroke among both men and women, but there may be an increased risk of MI and hemorrhagic stroke only among women.

PLOS MEDICINE (2023)

Article Cardiac & Cardiovascular Systems

Hemodynamic Effects of Ketone Bodies in Patients With Pulmonary Hypertension

Roni Nielsen, Kristian Hylleberg Christensen, Nigopan Gopalasingam, Kristoffer Berg-Hansen, Jacob Seefeldt, Casper Homilius, Ebbe Boedtkjer, Mads Jonsson Andersen, Henrik Wiggers, Niels Moller, Hans Erik Botker, Soren Mellemkjaer

Summary: The study demonstrates that 3-hydroxybutyrate (3-OHB) infusion in patients with PAH or CTEPH can decrease pulmonary vascular resistance, improve cardiac output, and enhance right ventricular function. Experimental rat studies also support the relaxing effect of ketone bodies on pulmonary arteries.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Endocrinology & Metabolism

Atorvastatin lowers Ga-68-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes

Reindert F. F. Oostveen, Yannick Kaiser, Mia R. R. Stahle, Nick S. S. Nurmohamed, Evangelos Tzolos, Marc R. R. Dweck, Jeffrey Kroon, Andrew J. J. Murphy, Damini Dey, Piotr J. J. Slomka, Hein J. J. Verberne, Erik S. G. Stroes, Nordin M. J. Hanssen

Summary: This study aimed to investigate the response of 68GaDOTATATE uptake in individuals with type 2 diabetes to therapeutic intervention. The results showed that after statin treatment, the uptake of 68GaDOTATATE in coronary arteries decreased, and the uptake in bone marrow and spleen also decreased. Therefore, 68GaDOTATATE can serve as an important marker for evaluating vascular and haematopoietic inflammation in individuals with type 2 diabetes undergoing intervention with anti-inflammatory therapeutics.

DIABETOLOGIA (2023)

Article Cardiac & Cardiovascular Systems

Aortic valve perivascular adipose tissue computed tomography attenuation in patients with aortic stenosis

Simona B. Botezatu, Xinming Yu, Mohammed N. Meah, Michelle C. Williams, Damini Dey, David E. Newby, Evangelos Tzolos, Marc R. Dweck

Summary: CT-derived aortic valve perivascular adipose tissue attenuation is not associated with AS disease severity, activity or progression, suggesting it has no value in the investigation and management of patients with AS.

HEART (2023)

Article Cardiac & Cardiovascular Systems

Ketone body 3-hydroxybutyrate elevates cardiac output through peripheral vasorelaxation and enhanced cardiac contractility

Casper Homilius, Jacob Marthinsen Seefeldt, Julie Sorensen Axelsen, Tina Myhre Pedersen, Trine Monberg Sorensen, Roni Nielsen, Henrik Wiggers, Jakob Hansen, Vladimir V. Matchkov, Hans Erik Botker, Ebbe Boedtkjer

Summary: The ketone body 3-hydroxybutyrate (3-OHB) directly acts on the heart to increase cardiac contractility and directly acts on blood vessels to lower systemic vascular resistance, leading to increased cardiac output and improved coronary perfusion. This finding strengthens the therapeutic rationale for 3-OHB in heart failure management.

BASIC RESEARCH IN CARDIOLOGY (2023)

No Data Available